SEARCH

SEARCH BY CITATION

References

  • 1
    Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271:13281334.
  • 2
    Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327:453457.
  • 3
    Gutersohn T, Steffen R, Van Damme P, et al. Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination. Aviat Space Environ Med 1996; 67:153156.
  • 4
    Ambrosch F, Wiedermann G, Jonas S, et al. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine. Vaccine 1997; 15:12091213.
  • 5
    Just M, Berger R, Dreschsler H, et al. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Vaccine 1992; 10:737739.
  • 6
    Loutan L, Bovier P, Althaus B, et al. Inactivated virosome hepatitis A vaccine. Lancet 1994; 343:322324.
  • 7
    Robertson S, Hull B, Tomori O, et al. Yellow fever. A decade of reemergence. JAMA 1996; 276:11571162.
  • 8
    Yvonnet B, Coursaget P, Deubel V, et al. Simultaneous administration of hepatitis B and yellow fever vaccine. J Med Virol 1986; 19:307311.
  • 9
    Mouchon D, Pignon D, Vicens R, et al. Étude de la vaccination combinée rougeole-fièvre jaune chez l'enfant africain âgé de 6 à 10 mois. Bull Soc Path Exot 1990; 83:537551.
  • 10
    Ambrosch F, Fritzell B, Gregor J, et al. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine 1994; 12:625628.
  • 11
    Bovier P, Loutan L. Vaccin inactive a virosome contre l'hepatite A: variation de la reponse immunitaire en cas d'administration simultanee d'autres vaccins, Abstract no P213. Schweiz Med Wschr 1993; 123:10.
  • 12
    WHO. Prevention and control of yellow fever in Africa. The World Health Organization, Geneva , 1986.
  • 13
    Felsenfeld O, Wolf RH, Gyr K, et al. Simultaneous vaccinations against cholera and yellow fever. Lancet 1973; 1:457458.
  • 14
    Kallinowski B, Bock HL, Clemens R, et al. Immunogenicity and reactogenicity of a combined hepatitis A/B candidate vaccine: first results. Liver 1996; 16:271273.
  • 15
    Ambrosch F, Andre FE, Delem A, et al. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine 1992; 10:142145.
  • 16
    Van Hoecke C, Lebacq E, Beran J, et al. Concomittant vaccination against hepatitis A and typhoid fever. J Travel Med 1998; 5:116120.
  • 17
    Vodopija I, Clemens R, Baklaic Z, et al. Feasibility of combined administration of hepatitis A and typhoid fever vaccines for vaccination of travelers. J Travel Med 1995; 2:120.
  • 18
    Mengiardi B, Berger R, Just M, et al. Virosomes as carriers for combined vaccines. Vaccine 1995; 13:13061315.
  • 19
    Schutze M, Deriaud E, Przewlocki G, et al. Carrier-induced epitopic suppression is initiated through clonal dominance. J Immunol 1989; 142:26352640.
  • 20
    Holzer BR, Hatz C, Schmidt-Sissolak D, et al. Immunogenicity and adverse effects of inactivated virosome versus alumadsorbed hepatitis A vaccine: a randomized controlled trial. Vaccine 1996; 14:982986.
  • 21
    Maiwald H, Jilg W, Bock H, et al. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine. Vaccine 1997; 15:346348.
  • 22
    Goudeau A, Denis F, Mounier M, et al. Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers. Postgrad Med J 1987; 63: 125128.
  • 23
    Wood RC, MacDonald KL, White KE, et al. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270: 29352939.
  • 24
    Roome AJ, Walsh SJ, Cartter ML, et al. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993; 270:29312934.
  • 25
    Margolis HS, Presson AC. Host factors related to poor immunogenicity of hepatitis B vaccine in adults: another reason to immunize early. JAMA 1993; 270:29712972.